CG Thomson, TD Aicher, W Cheng, H Du… - Journal of Medicinal …, 2024 - ACS Publications
A series of activators of GCN2 (general control nonderepressible 2) kinase have been
developed, leading to HC-7366, which has entered the clinic as an antitumor therapy …